-transparent.png){kind=logo}
The formation of reactive oxygen intermediates (ROI) during redox cycling of newly synthesized potential antitumor 2,5-bis (1-aziridinyl)-1,4-benzoquinone (BABQ) derivatives has been studied by assaying the production of ROI (superoxide, hydroxyl radical, and hydrogen peroxide) by xanthine oxidase in the presence of BABQ derivatives. At low concentrations (< 10 microM) some BABQ derivatives turned out to inhibit the production of superoxide and hydroxyl radicals by xanthine oxidase, while the effect on the xanthine-oxidase-induced production of hydrogen peroxide was much less pronounced. Induction of DNA strand breaks by reactive oxygen species generated by xanthine oxidase was also inhibited by BABQ derivatives. The DNA damage was comparable to the amount of hydroxyl radicals produced. The inhibiting effect on hydroxyl radical production can be explained as a consequence of the lowered level of superoxide, which disrupts the Haber-Weiss reaction sequence. The inhibitory effect of BABQ derivatives on superoxide formation correlated with their one-electron reduction potentials: BABQ derivatives with a high reduction potential scavenge superoxide anion radicals produced by xanthine oxidase, leading to reduced BABQ species and production of hydrogen peroxide from reoxidation of reduced BABQ. This study, using a unique series of BABQ derivatives with an extended range of reduction potentials, demonstrates that the formation of superoxide and hydroxyl radicals by bioreductively activated antitumor quinones can in principle be uncoupled from alkylating activity.
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
May 1993,
Archives of biochemistry and biophysics,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
January 2002,
Sub-cellular biochemistry,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
January 1991,
The Journal of pharmacology and experimental therapeutics,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
March 2023,
Chemico-biological interactions,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
December 2007,
Drug metabolism letters,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
November 1994,
Archives of biochemistry and biophysics,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
June 1989,
The Biochemical journal,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
January 1989,
Progress in clinical and biological research,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
August 1994,
Toxicology in vitro : an international journal published in association with BIBRA,
K J Lusthof, and
N J de Mol, and
W Richter, and
L H Janssen, and
J Butler, and
B M Hoey, and
W Verboom, and
D N Reinhoudt
January 1996,
Archives of toxicology,
